METAVIA INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
METAVIA INC. (MTVA) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 82.90% for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-14.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2024-08-14
- METAVIA INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2023-03-31 was 82.90%, a 2.73% increase year-over-year.
- METAVIA INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2022-03-31 was 80.70%.
- METAVIA INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2021-09-30 was 79.00%, a 2.86% increase year-over-year.
- METAVIA INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2020-09-30 was 76.80%.
- METAVIA INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2020 was 77.40%, a 3.20% increase from fiscal 2019.
- METAVIA INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2019 was 75.00%, a 13.12% increase from fiscal 2018.
- METAVIA INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2018 was 66.30%, a 0.76% increase from fiscal 2017.
- METAVIA INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2017 was 65.80%, a 7.90% decline from fiscal 2016.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month as first filed |
|---|---|---|---|---|---|
| 2024-06-30 | 82.90% 10-Q · filed 2024-08-14 | ||||
| 2023-06-30 | 82.90% 10-Q · filed 2023-08-09 | ||||
| 2023-03-31 | 82.90% 10-Q · filed 2023-05-12 | ||||
| 2022-03-31 | 80.70% 10-Q · filed 2023-05-12 | ||||
| 2021-09-30 | 79.00% 10-Q · filed 2021-11-15 | 79.00% 10-Q · filed 2022-11-14 | |||
| 2020-12-31 | 77.40% 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | 76.80% 10-Q · filed 2021-11-15 | 77.40% 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | 77.50% 10-Q · filed 2021-08-16 | ||||
| 2020-03-31 | 77.50% 10-Q · filed 2021-05-17 | ||||
| 2019-12-31 | 75.00% 10-K · filed 2021-04-15 | ||||
| 2019-09-30 | 75.00% 10-Q · filed 2020-11-13 | ||||
| 2019-06-30 | 75.00% 10-Q · filed 2020-08-11 | ||||
| 2019-03-31 | 75.00% 10-Q · filed 2020-05-20 | ||||
| 2018-12-31 | 66.30% 10-K · filed 2019-03-18 | ||||
| 2018-09-30 | 66.30% 10-Q · filed 2019-11-08 | ||||
| 2018-06-30 | 66.00% 10-Q · filed 2019-08-09 | 66.30% 10-Q · filed 2019-08-09 | |||
| 2018-03-31 | 66.50% 10-Q · filed 2019-05-09 | ||||
| 2017-12-31 | 65.80% 10-K · filed 2019-03-18 | ||||
| 2017-09-30 | 66.50% 10-Q · filed 2018-11-08 | 65.80% 10-Q · filed 2018-11-08 | |||
| 2017-06-30 | 66.60% 10-Q · filed 2018-08-14 | 65.60% 10-Q · filed 2018-08-14 | |||
| 2017-03-31 | 65.10% 10-Q · filed 2018-05-08 | ||||
| 2016-12-31 | 71.45% 10-K · filed 2019-03-18 | 71.40% 10-K · filed 2017-03-21 | |||
| 2016-09-30 | 71.30% 10-Q · filed 2017-11-13 | 71.30% 10-Q · filed 2017-11-13 | |||
| 2015-12-31 | 71.00% 10-K · filed 2018-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |